Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the Phase 1 trial of CRB-913 for the treatment of obesity ...

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 4.66% to $5.52 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index ...

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slid 2.95% to $5.92 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index ...

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has hit a 52-week low, trading at $5.91, down dramatically from its... Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has hit a ...

In front of an audience at the Boulder International Film Festival, the actress reflects on a career that, against all odds, only really took off after she turned 40. By Scott Feinberg Executive ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...